Statins nanocrystal as well as preparation method and application thereof

The invention provides a statins nanocrystal as well as a preparation method and application thereof. The statins nanocrystal is mainly prepared from statins, a stabilizer and a freeze-drying protective additive as raw materials; and the weight ratio of the statins to the stabilizing agent to the fr...

Full description

Saved in:
Bibliographic Details
Main Authors LUO TENGSHUO, ZHOU JING'E, DING NANJIN, YAN ZHIQIANG, LUO SHENGGEN
Format Patent
LanguageChinese
English
Published 28.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a statins nanocrystal as well as a preparation method and application thereof. The statins nanocrystal is mainly prepared from statins, a stabilizer and a freeze-drying protective additive as raw materials; and the weight ratio of the statins to the stabilizing agent to the freeze-drying protective agent is (1-10): (2-12): (0-40). The statins nanocrystal has the following technical effects that compared with statins free drugs, the statins nanocrystal shows that the blood vessel density at a tissue ischemic part is remarkably increased, particularly, the accumulation in the lung is increased, the lung blood vessel density is enhanced, and the statins nanocrystal has a remarkable curative effect on treating tissue ischemic diseases and can increase the blood vessel density of ischemic tissues and dredge blood vessels. 本发明提供了一种他汀类药物纳米晶及其制备方法和用途。本发明的他汀类药物的纳米晶,主要由他汀类药物、稳定剂和冻干保护剂为原料制成;所述的他汀类药物、稳定剂、冻干保护剂重量的比例为(1~10):(2~12):(0~40)。本发明具有如下技术效果:本发明的他汀类药物纳米晶,相对于他汀类游离药物,显示出在组织缺血部位的血管密度显著增加,特别是增加了在
Bibliography:Application Number: CN202111338585